FDA panel OKs Hologic's Selenia 3D mammography system

September 27, 2010 by MassDevice staff

The Food & Drug Administration's Radiological Devices Panel votes in favor of pre-market approval for Hologic Inc.'s Selenia Dimensions 3D digital mammography tomosynthesis device.

HOLX logo

Hologic Inc.'s (NSDQ:HOLX) Selenia Dimensions 3D digital mammography tomosynthesis system edged closer to approval from the Food & Drug Administration last week.

The device won unanimous favorable votes from the the agency's Radiological Devices Panel on effectiveness and safety and that the benefits of the system's technology outweigh its risks, according to the Bedford, Mass.-based company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp